Adalimumab therapy—a double-edged sword?

Saved in:
Bibliographic Details
Published inInternational journal of colorectal disease Vol. 26; no. 12; pp. 1621 - 1623
Main Authors O’Leary, Donal Peter, Myers, Eddie, Moran, Sarah, Browne, Tara-Jane, Harney, Sinead, Kirwan, William O.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.12.2011
Springer
Springer Nature B.V
Subjects
Adalimumab
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
Gastroenterology
Hepatology
Humans
Internal Medicine
Intestinal Perforation - chemically induced
Intestinal Perforation - complications
Laparotomy
Letter to the Editor
Medicine
Medicine & Public Health
Middle Aged
Proctology
Sepsis - chemically induced
Sepsis - complications
Surgery
Infliximab
Etanercept
Adalimumab
Thromboembolic Event
Bevacizumab
Online AccessGet full text

Cover

More Information
ISSN:0179-1958
1432-1262
DOI:10.1007/s00384-010-1114-3